Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can increase the risk of heart attacks and strokes.

Nick West, MD, cardiologist, chief medical officer, and divisional vice president of global medical affairs at Abbott's ...

Beyond the standard lipid profile, a new cardiology approach emphasizes inflammation, genetics, and vitamin deficiencies in ...

Experts discuss how knowledge of lipoprotein(a) (Lp[a]) levels can empower patients in managing atherosclerotic ...

Many Americans are unaware that elevated levels of this particle — known as lipoprotein(a) or Lp(a) — are circulating in their blood. Elevated Lp(a) cannot be modified with lifestyle changes ...

The main message is that absolute levels of Lp(a) matter more than which genes may have caused them, Robert Clarke says.

A new study has found that apolipoprotein B particle count and lipoprotein(a) count were critical indicators of risk for ...

Cardiovascular disease remains the world's top killer, but early detection through better blood testing could dramatically ...

A recent study published in the European Heart Journal investigated lipoproteins containing apolipoprotein B, a protein ...

In particular, the study suggests that hormone therapy may lower levels of lipoprotein(a), a genetic risk factor associated with a higher risk of heart attack and stroke. "The pendulum has been ...

For almost 60 years, measuring cholesterol levels in the blood has been the best way to identify individuals at high risk of ...

A recent study published in Obstetrics and Gynecology assesses hormone therapy (HT)-induced changes in cardiovascular ...